Emostatic-palliative radiotherapy in vescical carcinoma: two case reports
Radioterapia palliativa-emostatica nel carcinoma vescicale: due case reports.
Introduction: Palliative radiotherapy is very effective for symptoms control and it improves the quality of life of patients with neoplasia at any stage of the disease. The 5% of palliative radiotherapy treatments are carried out for hemostatic purposes and this approach is particularly useful in certain diseases. In fact in bladder cancer this treatment is able to control bleeding in more than 90% of cases.
Case description: We report two cases of old patients with urothelial carcinoma and macrohematuria, initially treated, for the fist time, with 20 Gy on the whole bladder obtainig completely resolution of hematuria. Afterwards, for new haematuria appearance, the patients were treated again with 15 Gy targeted on the progression region, obtaining resolution of bleeding again.
Conclusion: although a haemostatic approach does not give lasting results over time, a reprocessing should be considered due to the improvement in the quality of life that it may entail. (Oncology)
Gruppo di lavoro AIRO. Carta dei servizi della radioterapia palliativa in Italia. I ed, Febbraio 2017, pag 10. https://www.radioterapiaitalia.it/wp-content/uploads/2017/10/Carta-Servizi-Palliazione_Deliverable_1.0-1.pdf
Greco C, Trodella L. La gestione del sintomo con la radioterapia. Medic. 2014; 22(1): 43-52.
Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC Press. IARC Cancer Base 2001: 5.
De Vita V, Hellman S, Rosenberg SA. Cancer: Principles & Practice of Oncology. 6th edition (July 2001) Lippincott Williams & Wilkins:1396-415.
Galosi AB. Urological and Andrological disease in Emergency Room. 2017. https://doi.org/10.13140/rg.2.2.11837.26080
Chaw CL, Niblock PG, Chaw CS, Adamson DJ. The role of palliative radiotherapy for haemostasis in unresectable gastric cancer: a single-institution experience. Ecancermedicalscience. 2014;8:384..
Sundstrom S, Bremnes R, Aasebo U, et al. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol. 2004;22(5):801-10.
Srinivasan V, Brown CH, Turner AG. A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer. Clin Oncol (R Coll Radiol). 1994;6(1):11-3.
Bednaruk-Młynski E1, Senkus-Konefka E, Szewczyk P, Badzio A, Jassem J. Parallel-opposed fields vs. four fields, and two- (2D) vs. three-dimensional (3D) radiotherapy planning in thin patients with gynecological malignancies. Rep Pract Oncol Radiother. 2003; 8 (Suppl 2):S242.
Copyright (c) 2019 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors contributing to AboutOpen agree to publish their articles under the CC Attribution-NonCommercial-NoDerivatives 4.0 license, which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.